Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transforming Parkinson's care in Africa
ISRCTN77014546Phase 2Completed
- Sponsor
- Newcastle University
- Start
- May 2023
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Mucuna pruriens with Levodopa/carbidopa (2 arms). Primary endpoints: Parkinson's disease prevalence, Environmental risk factors for Parkinson's disease and 5 more. Started May 2023; status: completed.
02
Drugs
mucuna prurienslevodopa + carbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ISRCTN77014546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN77014546.